April 13, 2011 |
In the world of “promising” multiple sclerosis drugs, it’s been quite a week. Two more experimental drugs -- both in pill form, not injected -- are joining the race of new treatments to slow the disease. A study of multiple sclerosis patients who took the drug laquinimod over two years had 23% fewer relapses -- an attack of new symptoms or worsening of old ones -- compared with patients who took a sugar pill. The group that received the drug also had a 36% reduction in disability progression and a 33% reduction in brain atrophy.
April 3, 1988
It is unfortunate that your staff writer emphasized the debate over "safe drinking" rather than the deeper issue addressed by Herbert Fingarette's work, that of personal responsibility versus victimization. We are fast becoming a society of powerless automatons determined by blind forces of heredity, biochemistry, and disease. People who are conditioned to believe they have no choice eventually stop making the effort to choose. The disease theory of behavioral disorders is a 20th-Century version of "The devil made me do it."
CALIFORNIA | LOCAL
March 26, 1995
With reference to your article on March 10, " 'Flesh-Eating' Disease Kills Agoura Man," I feel that this is irresponsible journalism. Reporting the occurrence is one thing, but quoting Sandra Tyson, the attorney for the family of another patient who died of the disease, is totally inflammatory and serves no purpose. I feel Tyson should be sanctioned by the Ventura County Bar Assn. for commenting on a case of which she has no connection and knows no specific facts of the medical problems involved with same.
November 30, 2010 |
Walking may put the brakes on cognitive decline in healthy older people as well as those with cognitive impairment, a new study finds. The ongoing study, which spans 20 years, also quantified how much walking is necessary to keep brain volume up. Researchers followed 426 older adults for a number of years to see if there were changes in brain volume. Among the participants 299 were healthy, and 127 had cognitive impairments, including 83 with mild cognitive impairment, and 44 with Alzheimer's disease.
October 18, 2010
Doctors usually diagnose Alzheimer's disease through a combination of medical and cognitive tests along with a brain scan. New studies, even one involving family members and friends, offer the promise of making the diagnosis easier -- and maybe even earlier. An August study in the Archives of Neurology used biomarkers to correctly classify patients who had Alzheimer's disease. The study tested normal people without the disease, those with mild brain impairments and those with the disease.
April 12, 2011 |
Low-intensity walking may help people with Parkinson's disease improve their gait and mobility, a new study finds. The study, presented Tuesday at the American Academy of Neurology's annual meeting in Honolulu, compared three different forms of exercise to see which was most beneficial to men and women with Parkinson's disease, which affects motor control. Researchers randomly assigned 67 people with the disease to one of three programs: a low-intensity treadmill walk for 50 minutes; a high-intensity treadmill walk for 30 minutes; and a weight and stretching regimen that included leg presses, extensions and curls.
September 26, 2011 |
Men who don't have children may be at higher risk for cardiovascular disease, a study finds. The study, released Monday in the journal Human Reproduction , followed 137,903 male married or previously married AARP members for an average of about 10 years. At the beginning of the study, the participants, whose average age was about 63, had no history of heart disease, and 92% had fathered at least one child. Half had three or more children. During the course of the study, 3,082 men died due to cardiovascular causes.
November 15, 2010 |
Alzheimer's disease threatens more and more people in the United States as the population ages. Anyone concerned about himself or herself or a loved one can get a free memory screen Tuesday at one of more than 2,300 locations across the nation (Tuesday is the Alzheimer's Foundation of America's National Memory Screening Day). The five-minute screenings -- which are to be available at doctors' offices, hospitals, senior centers and K-Mart pharmacies, among other locations -- are confidential.